What You Should Know:
- Rockley Photonics Holdings Limited, a global leader in photonics-based health monitoring and communications solutions, recently announced that it has developed what it believes to be the world’s first micro-transfer-printed (mTP) silicon-photonics-based laser for commercial applications.
- This groundbreaking achievement is expected to allow Rockley to further increase the density and reduce the size of its high-density spectrophotometer chips — which are already
Read More
IntelyCare Launches The IntelyHeart Foundation, Committing $2M to Support Healthcare Professionals
What You Should Know:
- IntelyCare, a healthcare workforce management platform in the United States, today announced the launch of The IntelyHeart Foundation, a charitable not-for-profit organization.
- The IntelyHeart Foundation, with support from IntelyCare, will provide need-based grants to healthcare professionals who apply and meet established criteria. IntelyCare intends to commit up to $2 million over the next two years to fund grants to those who need short-term financial
Read More
New athenahealth Research Finds that Telehealth Fills Care Gaps
What You Should Know:
- Increased usage of telehealth, driven by COVID-19, not only remains substantially above pre-pandemic levels but has also emerged as both a key diagnostic tool and treatment vehicle, according to new research from athenahealth.
- The findings, announced today by athenahealth, a leading provider of network-enabled software and services for medical groups and health systems nationwide, suggest that telehealth is now integrated across the care continuum. The findings
Read More
Geneial Receives $2.3M NIH Grant for Decentralized Biomedical Data Platform
What You Should Know:
- Digital health company Geneial announces a $2.3M grant from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.
- Geneial will use $2.3M NIH award to build private, decentralized data platform facilitating research of genetic diseases. Geneial's platform will connect researchers of rare genetic diseases with relevant data while preserving patient privacy. Geneial's platform aims to help researchers leverage
Read More
Assisted Polyp Detection Device Receives FDA Clearance
What You Should Know:
- Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, and Provation, the premier software and SaaS provider of clinical productivity and workflow automation solutions, announced recently that SKOUT™ has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for adults undergoing colorectal cancer screening or surveillance.
- The device was evaluated in the largest U.S.-based multicenter clinical study for a
Read More
Virtual Reality Therapy May Serve as Effective Adjunct To Anesthesia For Surgical Procedures
What You Should Know:
- The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, published in PLOS ONE demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth’s immersive virtual reality software.
- The results of the trial showed that the majority of patients (13/17) using the XRHealth VR technology did not need
Read More
KLAS Report Explores EHR Satisfaction by Provider Specialty
What You Should Know:
- One of the ways organizations can target improvements for those who are less satisfied is to look at EHR satisfaction by specialty—there is currently a gap of about 30 points between the most satisfied specialty (hospital medicine) and the least satisfied specialty (ophthalmology).
- The goal of this new report from the KLAS Arch Collaborative, "Exploring EHR Satisfaction by Provider Specialty," is to help readers understand this variation and learn some ways the
Read More
Naveris Raises $51M for Early Detection of Viral-Driven Cancers
What You Should Know:
- Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M expansion of its Series A financing, bringing the total investment in Naveris to $51M.
- The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society.
Using DNA Fragmentomics Technology to Detect
Read More
BrightInsight & bioMérieux Partner to Develop Clinical Digital Solution for Diagnostics
What You Should Know:
- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions and bioMérieux, a world leader in the field of in vitro diagnostics, announced today a partnership to develop and bring to market a Clinical Digital Solution for diagnostics enabling clinical decision support for disease areas across their diagnostic tests.
- bioMérieux will launch a digital solution for diagnostics leveraging the compliant
Read More
Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies
What You Should Know:
- Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M in Series A financing to pioneer novel therapies to modulate mitochondrial function.
- The financing was led by ARCH Venture Partners and Mubadala Capital with participating investors HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, and
Read More
